NHS staff boycott Palantir’s data platform over ethical concerns

Published on April 2, 2026

NHS staff across the United Kingdom are staging a boycott against Palantir Technologies, a controversial American data analytics firm, following ethical concerns surrounding its £330 million contract awarded in 2023. The contract allows Palantir to collate sensitive hospital and patient information, raising alarms among healthcare professionals regarding data privacy and the potential misuse of personal data.

The decision to boycott stems from widespread fears that involving a private tech company in the management of NHS data could compromise patient confidentiality. NHS staff have expressed their outrage, emphasizing the importance of maintaining patient trust within the healthcare system. The boycott has gained momentum, with multiple unions and advocacy groups lending their support to the cause.

Palantir, known for its work with government agencies and law enforcement, has faced criticism previously for its practices and transparency. Critics argue that the company’s integration into the NHS could pave the way for invasive surveillance and undermine the core values of public healthcare. The controversy surrounding the contract has ignited discussions about the ethical implications of utilizing private tech firms within public health systems.

Supporters of the boycott have highlighted the need for a transparent dialogue about data usage and protection. They argue that the NHS should prioritize patient welfare above all else and ensure that any technological solutions in healthcare adhere to strict ethical standards. The NHS, facing mounting pressure, has committed to holding consultations with staff and stakeholders to address these vital concerns.

As the boycott continues, healthcare professionals are calling for a reevaluation of the contract with Palantir and advocating for alternative methods of data management that align better with the principles of transparency and accountability. The growing discontent signals a pivotal moment in the ongoing debate over the role of technology in public services, pushing for a more cautious approach to data governance in the NHS.

While Palantir maintains that its platform can deliver efficiencies and improvements in patient care, the backlash from NHS staff has raised critical questions about the balance between innovation and ethical responsibility in healthcare. As the situation develops, the NHS will need to navigate these complex issues to restore confidence among its workforce and the public.

Related News